510(k) K223722

MIO Blood Glucose Monitoring System by Mio Labs, Inc. — Product Code NBW

K223722 is an FDA 510(k) premarket notification submitted by Mio Labs, Inc. for the device "MIO Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Jun 28, 2023. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 28, 2023
Date Received
Dec 12, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Test, Blood Glucose, Over The Counter
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type
510(k)

Need the full FDA record for Mio Labs, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K223722. Report a data issue: hello@regdatalab.com.